knowledge -WSS

knowledge

author：leisure time 2025-09-29 01:37:56 - browse：57116

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Anthos stroke drug appears safer than common blood thinner

entertainment

WSS

Weight loss drug costs may need more research, senator suggests

Hospitals look to new technology to keep health care workers safe

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Extensive review finds private equity owners jack up cost of care

Scientists grapple with ethics of stem cell research

Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

knowledge

explore

Psychedelics group wrestles with new pharma identity

5 dead in mass shooting on Caribbean island of St. Vincent: Police

After affirmative action ruling, medical educators look to 'holistic review'

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

New air purifier tech could be key to improving indoor air quality

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Sports medicine is finally prioritizing gender equality

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

State Dept. review finds Biden bears some blame for Afghanistan failures

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

hotspot

5 dead in mass shooting on Caribbean island of St. Vincent: Police

FDA's Woodcock to retire early next year

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Astellas still sees hope in its gene therapy after four deaths

Surge of respiratory disease in China has likely explanation

Caribou posts encouraging results on off

Wikipedia

entertainment

entertainment

leisure time